Cargando…
Neutron crystallography aids in drug design
Since drugs bind to their targets through directional H bonding and non-directional hydrophobic and electrostatic interactions, neutron crystallography can help guide structure-based drug design. This is illustrated by McKenna and co-workers [Aggarwal et al. (2016), IUCrJ, 3, 319–325] who describe t...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391850/ https://www.ncbi.nlm.nih.gov/pubmed/28461889 http://dx.doi.org/10.1107/S2052252516013439 |
_version_ | 1783229345600372736 |
---|---|
author | Blakeley, M. P. |
author_facet | Blakeley, M. P. |
author_sort | Blakeley, M. P. |
collection | PubMed |
description | Since drugs bind to their targets through directional H bonding and non-directional hydrophobic and electrostatic interactions, neutron crystallography can help guide structure-based drug design. This is illustrated by McKenna and co-workers [Aggarwal et al. (2016), IUCrJ, 3, 319–325] who describe the room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor methazolamide to 2.2 Å resolution, and compare this with the previously determined room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor acetazolamide to 2.0 Å resolution [Fisher et al. (2012). J. Am. Chem. Soc.134, 14726–14729]. |
format | Online Article Text |
id | pubmed-5391850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-53918502017-05-01 Neutron crystallography aids in drug design Blakeley, M. P. IUCrJ Scientific Commentaries Since drugs bind to their targets through directional H bonding and non-directional hydrophobic and electrostatic interactions, neutron crystallography can help guide structure-based drug design. This is illustrated by McKenna and co-workers [Aggarwal et al. (2016), IUCrJ, 3, 319–325] who describe the room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor methazolamide to 2.2 Å resolution, and compare this with the previously determined room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor acetazolamide to 2.0 Å resolution [Fisher et al. (2012). J. Am. Chem. Soc.134, 14726–14729]. International Union of Crystallography 2016-08-31 /pmc/articles/PMC5391850/ /pubmed/28461889 http://dx.doi.org/10.1107/S2052252516013439 Text en © M. P. Blakeley 2016 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Scientific Commentaries Blakeley, M. P. Neutron crystallography aids in drug design |
title | Neutron crystallography aids in drug design |
title_full | Neutron crystallography aids in drug design |
title_fullStr | Neutron crystallography aids in drug design |
title_full_unstemmed | Neutron crystallography aids in drug design |
title_short | Neutron crystallography aids in drug design |
title_sort | neutron crystallography aids in drug design |
topic | Scientific Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391850/ https://www.ncbi.nlm.nih.gov/pubmed/28461889 http://dx.doi.org/10.1107/S2052252516013439 |
work_keys_str_mv | AT blakeleymp neutroncrystallographyaidsindrugdesign |